Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20312)

• Formulation Name: Sodium phenylbutyrate 500 mg tablet
• Company: Hyperion Therapeutics

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sodium phenylbutyrate	(DMXLBCQ)	Spinal muscular atrophy	8B61	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent